Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hospira, originally the Hospital Products Division of Abbott Laboratories, is a global leader in injectable drugs and infusion technologies. The company specializes in the development and manufacture of generic injectable pharmaceuticals, biosimilars, and medication management systems including infusion pumps. Following its spin-off from Abbott in 2004, Hospira established itself as a dominant player in the hospital supply market before being acquired by Pfizer in 2015. Today, it operates as a core component of Pfizer's sterile injectables and biosimilars portfolio, providing critical care products to healthcare facilities worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hospital Products.